Monographie - Amphotericin B cholesteryl sulfate complex

Pēdējā atjaunošana :
19/11/2024

Amphotericin B cholesteryl sulfate complex

Ķīmiskā uzbūve

Oriģinālais nosaukums

Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām

Amphotec

Amerikas Savienotās Valstis, Austrija, Grieķija, Lielbritānija, Polija, Slovēnija, Turcija

Literatūras saraksts : Amphotericin B cholesteryl sulfate complex

	tips	publicēšana
921	Žurnāls	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1407	Žurnāls	Xu QA, Trissel LA, Gilbert DL. Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture. Hosp Pharm 1998 ; 33: 1203-1207.
1982	Žurnāls	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2262	Žurnāls	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3578	Laboratorija	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3644	Laboratorija	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales